6-K ·Filed Nov 2, 2026
Notable filing: 6-K
Actionable Insight • Neutral
The dividend is a routine interim distribution; no material impact on the stock is expected. Monitor future filings for full-year earnings and any changes to the dividend policy.
GRFS drugs
GRFS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5Entry
$8.51
T+0 close · Nov 2, 2026 · via day close
Latest settled
+2.12%
T+5 · $8.69 · next T+20 in 14d
Vs SPY
+2.04%
α at T+5
Latest observation
+3.82%
T+9 · FF3 residual α
- T+0 · Nov 2 $8.51entry
- T+1 · 14d ago +0.59%α +0.29% · $8.56
- T+5 · 8d ago +2.12%α +2.04% · $8.69
- T+10 · todayOpen
- T+20 · in 14d Pending
- T+60 · in 2mo Pending
Price Chart
Loading chart...
How similar events traded
Executive Summary
Grifols' Board approved an interim dividend of €0.15 per share, payable on December 4, 2026. This is a routine capital allocation event with no financial results or guidance provided.
Key Facts
- Interim dividend of €0.15 per share approved by the Board on October 30, 2026.
- Payment date is December 4, 2026.
- Paying agent is Banco Bilbao Vizcaya Argentaria (BBVA).
Financial Impact
€0.15 per share interim dividend; total payout not disclosed.
dividend
Risk Factors
- No financial results or guidance in this filing; dividend alone does not signal underlying business performance.
Market Snapshot
Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (21 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-121157 |
| Document: 0001104659-26-121157-index-headers.html | 0001104659-26-121157 |
| Document: 0001104659-26-121157-index.html | 0001104659-26-121157 |
| Document: 0001104659-26-121157.txt | 0001104659-26-121157 |
| Earnings Context (Synthetic; results releases only) | 0001104659-26-121157 |
Track record
7 reports on GRFS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 2, 202614d ago 6-K Neutral 2/10 Viewing Entry $8.51 to $8.69 Now $8.73 +2.59% ▲ +2.12% +2.04% vs SPY
- Nov 2, 202614d ago 6-K Bullish 6/10 Entry $8.51 to $8.69 Now $8.73 +2.59% ▲ +2.12% +2.04% vs SPY
- Aug 10, 202614w ago Press Release Neutral 4/10 Entry $8.05 to $7.77 Now $8.73 +8.45% ▼ −3.48% −3.43% vs SPY
- Jul 30, 202615w ago 6-K Neutral 2/10 Entry $8.20 to $7.83 Now $8.73 +6.46% ▼ −4.51% −8.13% vs SPY
- Jul 16, 202617w ago Press Release Neutral 4/10 Entry $7.33 to $7.54 Now $8.73 +19.10% ▲ +2.86% +4.54% vs SPY
- Jun 18, 202621w ago 6-K Neutral 3/10 Entry $7.28 to $7.39 Now $8.73 +19.92% ▲ +1.51% +3.58% vs SPY
- Mar 17, 202634w ago Press Release Bullish 7/10 Entry $8.02 to $7.60 Now $8.73 +8.85% ▼ −5.24% −2.58% vs SPY
Showing 7 of 7
US Market Status
Market Closed · Opens Wed (11h 18m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers